Yahoo Web Search

Search results

  1. Lilly is a medicine company turning science into healing to make life better for people around the world.

  2. Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries.

  3. [Lilly logo and "A Medicine Company" appear over the last scene.] When health is lost, the only thing you want is to get better. In our relentless pursuit to help the most people around the world, our pipeline is focused on the following key areas:

  4. Eli Lilly and Company works tirelessly to develop and deliver trusted medicines that meet real needs. These include Trulicity, Humalog, Alimta, Forteo, Taltz, Humulin, Basaglar, Jardiance, Cyramza, REYVOW, Verzenio, Emgality and more.

  5. Find the latest Eli Lilly and Company (LLY) stock quote, history, news and other vital information to help you with your stock trading and investing.

  6. Eli Lilly and Company | 1,890,803 followers on LinkedIn. We're a medicine company turning science into healing to make life better for people around the world.

  7. Find your place at Lilly with Lilly Careers. For more than a century, we have united caring with discovery to make life better, join us today.

  8. investor.lilly.com › static-files › 75718118/4339/4ea6-9086-cb9201a2d926ELI LILLY AND COMPANY

    Aug 8, 2024 · For additional information about the factors that affect the company's business, please see the company's latest Form 10-K and subsequent Forms 10-Q and 8-K filed with the Securities and Exchange Commission.

  9. Sep 13, 2024 · The Investor Relations website contains information about Eli Lilly and Company's business for stockholders, potential investors, and financial analysts.

  10. Jul 14, 2023 · INDIANAPOLIS and NEW YORK, July 14, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Versanis Bio today announced a definitive agreement for Lilly to acquire Versanis, a private clinical-stage biopharmaceutical company focused on the development of new medicines for the treatment of cardiometabolic diseases.